Key result
Fulminant myocarditis linked to ~11% higher fractional shortening at six months vs acute myocarditis.
Why the study?
The clinical course of patients with myocarditis remains poorly defined, prompting assessment of whether echocardiography can distinguish fulminant from acute myocarditis at presentation and evaluate potential for LV functional recovery.
Does echocardiography distinguish fulminant from acute myocarditis and predict recovery of left ventricular function?
Observational (n=54)
Does echocardiography distinguish fulminant from acute myocarditis and predict recovery of left ventricular function?
Answers are grounded in this paper and cite their sources.
Echocardiography can distinguish fulminant from acute myocarditis at presentation and demonstrates that fulminant myocarditis is associated with substantial recovery of ventricular function at 6 months.
OBJECTIVES: We sought to use echocardiography to assess the presentation and potential for recovery of left ventricular (LV) function of patients with fulminant myocarditis compared with those with acute myocarditis. BACKGROUND: The clinical course of patients with myocarditis remains poorly defined. We have previously proposed a classification that provides prognostic information in myocarditis patients. Fulminant myocarditis causes a distinct onset of illness and severe hemodynamic compromise, whereas acute myocarditis has an indistinct presentation, less severe hemodynamic compromise and a greater likelihood of progression to dilated cardiomyopathy. METHODS: Echocardiography was performed at presentation and at six months to test the hypothesis that fulminant (n = 11) or acute (n = 43) myocarditis could be distinguished morphologically. RESULTS: Patients with both fulminant (fractional shortening 19 +/- 4%) and acute myocarditis (17 +/- 7%) had LV systolic dysfunction. Patients with fulminant myocarditis had near normal LV diastolic dimensions (5.3 +/- 0.9 cm) but increased septal thickness (1.2 +/- 0.2 cm) at presentation, while those with acute myocarditis had increased diastolic dimensions (6.1 +/- 0.8 cm, p < 0.01 vs. fulminant) but normal septal thickness (1.0 +/- 0.1 cm, p = 0.01 vs. fulminant). At six months, patients with fulminant myocarditis had dramatic improvement in fractional shortening (30 +/- 8%) compared with no improvement in patients with acute myocarditis (19 +/- 7%, p < 0.01 for interaction between time and type of myocarditis). CONCLUSIONS: Fulminant myocarditis is distinguishable from acute myocarditis by echocardiography. Patients with fulminant myocarditis exhibit a substantial improvement in ventricular function at six months compared with those with acute myocarditis. Echocardiography has value in classifying patients with myocarditis and may provide prognostic information.
No takes yet. Share an insight, caveat, or question.
Felker et al. (2000) conducted an observational in Fulminant and acute myocarditis (n=54). Fulminant myocarditis vs. Acute myocarditis was evaluated on Fractional shortening at six months (p=<0.01). Fulminant myocarditis was associated with a dramatic improvement in fractional shortening at six months compared with acute myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: